Qyuns Therapeutics Co Ltd (2509.HK)

HKD 11.24

(1.81%)

Operating Income Summary of Qyuns Therapeutics Co Ltd

  • Qyuns Therapeutics Co Ltd's latest annual operating income in 2023 was -504.51 Million CNY , down -50.58% from previous year.
  • Qyuns Therapeutics Co Ltd's latest quarterly operating income in 2024 Q2 was -84.61 Million CNY , down 0.0% from previous quarter.
  • Qyuns Therapeutics Co Ltd reported an annual operating income of -388.18 Million CNY in 2022, down -60.49% from previous year.
  • Qyuns Therapeutics Co Ltd reported an annual operating income of -241.87 Million CNY in 2021, down 0.0% from previous year.
  • Qyuns Therapeutics Co Ltd reported a quarterly operating income of -84.61 Million CNY for 2024 Q1, up 45.06% from previous quarter.
  • Qyuns Therapeutics Co Ltd reported a quarterly operating income of -154.02 Million CNY for 2023 Q4, down -33.32% from previous quarter.

Annual Operating Income Chart of Qyuns Therapeutics Co Ltd (2023 - 2021)

Historical Annual Operating Income of Qyuns Therapeutics Co Ltd (2023 - 2021)

Year Operating Income Operating Income Growth
2023 -504.51 Million CNY -50.58%
2022 -388.18 Million CNY -60.49%
2021 -241.87 Million CNY 0.0%

Peer Operating Income Comparison of Qyuns Therapeutics Co Ltd

Name Operating Income Operating Income Difference
Uni-Bio Science Group Limited 67.76 Million HKD 844.469%
CK Life Sciences Int'l., (Holdings) Inc. 897.95 Million HKD 156.185%